| | | 2021 Review and looking to 2022
The gig for 2021 was to focus on increasing dividend growth through the purchase of fairly valued or undervalued mid-yield stocks with dividend growth greater than 5% - that also had excellent dividend safety ratings. My assumption is that many financial stats make up, in large part, the dividend safety rating.
So, during 11 months of 2021 My focus was building SCHD, an ETF that is yielding 2.78% as I type this, has a most recent annual dividend increase of 10.8% and a 5 year DGR of 12%. It is now our second largest position at 5.7% of our combined portfolios.
Then came December. I sold DUK and bought D with the proceeds. I started positions in EOG and RY.
I decided to trim some of our gains in JNJ, DLR and PEP, and used those proceeds to bring D, EOG, and LMT up to full positions. DLR is still our largest position and JNJ & PEP are still full weight.
Looking to 2022, that leaves our most recent new position, RY as underweight. Objective 1 - build up RY to a full weight position. It is not half way there yet. I will probably trim some gains from CSCO and use those proceeds on RY. That would take RY up to just over half-weight. The rest will come from putting accumulated dividends into RY.
That is the plan, anyway. |
|
